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Cell Culture Assay 
for Human 
Noroviruses 
To the Editor: We read with 
great interest the article on human no-
rovirus (hNoV) by Straub et al. (1). 
By using 3-dimensional aggregates 
of a highly differentiated intestinal 
epithelial cell line, the investigators 
claimed to have established an in vitro 
cell culture model that “support[s] the 
natural growth of human noroviruses.” 
While the authors provide compelling 
evidence of successful virus infection 
through microscopy, hybridization of 
viral RNA after 5 passages in cell cul-
ture, and preliminary evidence of vi-
ral RNA replication through limiting 
dilution PCR, we question the level 
of virus replication that is actually 
achieved in this system.
Straub et al. demonstrate through 
ﬂ   uorescent in situ hybridization the 
presence of viral RNA through 5 pas-
sages in his system. This phenomenon 
could be similar to the ﬁ   ndings  of   
Duizer et al. (2), if the level of replica-
tion simply maintained the viral titer. 
Therefore, we argue that virus replica-
tion curve, estimated by using quan-
titative real-time PCR or semiquan-
titative endpoint dilution PCR with 
the end-dilution of each sample from 
different time points in this system, 
will conclusively determine the suit-
ability of this model as a productive 
virus replication system. To support 
our hypothesis, we point to the pig 
model for hNoV infectivity (3). In that 
study investigators failed to observe 
an increase in viral shedding from 
symptomatic piglets upon serial pas-
sage, despite successful intracellular 
detection of viral RNA and newly syn-
thesized virus-encoded protein in host 
cells dying of apoptosis. This suggests 
that the demonstration of cytopathic 
effect and virus internalization in cells 
alone may not provide direct evidence 
of productive virus replication. In con-
clusion, although we acknowledge that 
Straub et al. have provided evidence 
of successful hNoV infection in vitro, 
we suggest subsequent studies to char-
acterize the level of virus replication 
in this system.
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In Response: We appreciate the 
comments provided by Chan et al., in 
response to our recently published arti-
cle (1). The speciﬁ  c aim of our project 
was to develop an in vitro cell culture 
infectivity assay for human norovirus 
(hNoV) to enhance risk assessments 
when these viruses are detected in 
water supplies. Reverse transcription 
(RT) qualitative or quantitative PCR 
are the primary assays for waterborne 
hNoV monitoring. However, these 
assays cannot distinguish infectious 
from noninfectious virions. When 
hNoV is detected in water supplies, 
information provided by our infectiv-
ity assay will improve risk assessment 
models and protect human health, re-
gardless of whether we are propagat-
ing hNoV. Indeed, in vitro cell culture 
infectivity assays for the waterborne 
pathogen  Cryptosporidium parvum 
that supplement approved ﬂ  uorescent 
microscopy assays do not result in am-
pliﬁ  cation of the environmentally re-
sistant hard-walled oocysts (2). How-
ever, identiﬁ  cation of life cycle stages 
in cell culture provides evidence of 
infectious oocysts in a water supply.
Nonetheless, Leung et al.’s as-
sertion regarding the suitability of 
our method for the in vitro propaga-
tion of high titers of hNoV is valid 
for the medical research community. 
In this case, well-characterized chal-
lenge pools of virus would be useful 
for developing and testing diagnostics, 
therapeutics, and vaccines. As further 
validation of our published ﬁ  ndings, 
we have now optimized RT quantita-
tive PCR to assess the level of viral 
production in cell culture, where we 
are ﬁ  nding increases in viral titer. The 
magnitude and time course of these 
increases is dependent on both virus 
strain and multiplicity of infection. 
We are currently preparing a manu-
script that will discuss these ﬁ  ndings 
in greater detail, and the implications 
this may have for creating viral chal-
lenge pools.
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Anthrax in Red 
Deer (Cervus 
elaphus), Italy 
To the Editor: Anthrax is hypo-
endemic in Italy; a few outbreaks oc-
curred yearly involving unvaccinated 
herbivores on pastures in central and 
southern regions and the major islands. 
Multiple-locus variable-number tan-
dem-repeat analysis (MLVA) with 8 
variable-number tandem repeats (VN-
TRs) of Italian isolates of Bacillus an-
thracis has identiﬁ  ed 9 genotypes be-
longing to cluster A1a (1). An isolate of 
cluster A3 has been identiﬁ  ed recently 
in Sardinia, which suggests that such a 
strain could have been introduced into 
Italy from another country (1).
A total of 37 anthrax outbreaks oc-
curred in a 41-day period from August 
28 to October 3, 2004, in a restricted 
area of Pollino National Park (Basili-
cata region in southern Italy) and re-
sulted in the deaths of 124 domestic or 
wild animals. Two suspected cases of 
cutaneous anthrax in humans were re-
corded. Pollino National Park contains 
several species of feral animals. Since 
1990, there has been a program for rein-
troduction of red deer (Cervus elaphus) 
into this park from Tuscany, Italy, and 
Carinthia, Austria. The animals are kept 
in quarantine in a corral by the veteri-
nary services of the park and given an 
electronic tag before their release. At 
the time of the anthrax outbreaks, the 
red deer population of the park was 45, 
of which 10 were living in the corral. 
These outbreaks killed 8 deer (4 free-
ranging and 4 conﬁ  ned animals).
Each carcass was examined by 
the veterinary ofﬁ  cer, who collected 
clinical samples that were examined 
for B. anthracis by using standard pro-
cedures of the Istituto Zooproﬁ  lattico 
Sperimentale of Puglia and Basilicata. 
DNA from the suspected colonies was 
analyzed by PCR with primers specif-
ic for B. anthracis (2) and subsequent 
genotyping by using MLVA with 8 
VNTRs (3). All B. anthracis isolates 
belonged to cluster A1a, genotype 
1 (A. Fasanella, unpub. data). This 
genotype was also identiﬁ  ed in sub-
sequent outbreaks that involved farm 
animals in the same area and resulted 
in the deaths of 116 domestic animals, 
including 81 cattle, 15 sheep, 9 goats, 
and 11 horses. Red deer showed the 
highest mortality rate during these 
outbreaks (Table). An ELISA (4) per-
formed with 27 serum samples ob-
tained from deer in the park detected 
low levels of antibodies to B. anthra-
cis in 22% of the examined animals. 
This seroprevalence is consistent with 
levels found in unvaccinated livestock 
reared in areas endemic for anthrax 
(A. Fasanella, unpub. data). 
A vaccination program was then 
instituted for farm animals, but the 
deer population in the park was ex-
cluded because no experimental data 
were available on the safety and ef-
ﬁ   cacy of Carbosap vaccine (Istituto 
Zooproﬁ  lattico Sperimentale of Pug-
lia and Basilicata, Foggia, Italy)  in 
wild ruminants. Extensive vaccination 
limited the outbreaks in livestock and 
red deer, which probably prevented 
further spread of infection from farm 
animals to free-ranging deer.
These anthrax outbreaks in south-
ern Italy suggested that red deer are 
highly susceptible to infection with B. 
anthracis and that the mortality rate in 
these deer could be even higher than 
that observed in domestic animals. Al-
though epidemiologic data are limited 
and need to be supported experimen-
tally by assessment of the 50% lethal 
dose of B. anthracis in red deer, the 
ecologic effect on deer populations in 
parks should not be underestimated. 
Moreover, concerns for public health 
may arise in parks in disease-endemic 
areas, where susceptible wild animals 
could represent an ampliﬁ  cation fac-
tor for B. anthracis spores, which in-
creases the probability of outbreaks 
in domestic animals and in humans 
living near, working in, or visiting the 
parks. This article stresses the need for 
evaluating the safety and efﬁ  cacy of B. 
anthracis vaccines in deer and for in-
cluding wild ruminants in the anthrax 
prophylaxis programs.
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Table. Mortality rates during anthrax outbreaks, Italy, 2004 
Animal Population of area  No. (%) dead animals 
Cattle ≈7,000 81 (≈1.15) 
Sheep ≈20,000 15 (≈0.075) 
Goats ≈13,000 9 (≈0.069) 
Horses ≈600 11 (≈1.83) 
Red deer  45 8 (≈17.77) 